![John DeMattei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
John DeMattei has worked as the Chief Operating Officer & Senior VP-Chemistry at OnKure, Inc. since 2018.
Posizioni attive di John DeMattei
Società | Posizione | Inizio |
---|---|---|
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Direttore operativo | 01/03/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Health Technology |
- Borsa valori
- Insiders
- John DeMattei